Zobrazeno 1 - 10
of 118
pro vyhledávání: '"S. Niccolini"'
Autor:
S. Niccolini, F. Chellini, F. Baldi, P. Ferrata, D. Gambera, C. Capperucci, B. Frediani, A. Spreafico, L. Bocchi, R. Marcolongo
Publikováno v:
Reumatismo, Vol 58, Iss 4, Pp 288-300 (2011)
Bisphosphonates (BPs) are pharmacological compounds widely used in the treatment of a variety of bone-related diseases, particularly where the bone-turnover is skewed in favour of osteolysis. The mechanisms by which BPs reduce bone-resorption directl
Externí odkaz:
https://doaj.org/article/680a57bbec694cb4ad1c21fb3503f226
Autor:
L, Masotti, V, Stefanelli, N, Veneziani, D, Calamassi, P, Morino, S, Niccolini, F, Dainelli, F, Maggi, A, Marchese, S, Cianti, A, Geraci, R, Vecchio, A, Carli Ballola, S, Regoli
Publikováno v:
La Clinica terapeutica. 172(2)
Appropriate end of life (EOL) management in Internal Medicine wards is challanging. The aim of this study was to analyze the burden of an educational program on EOL management in a Internal Medicine ward. Materials and methods: We retrospectively ana
Autor:
Pier Leopoldo Capecchi, Mauro Galeazzi, Pietro Enea Lazzerini, S. Niccolini, Franco Laghi-Pasini, Paolo Ferrata, Bruno Frediani, Caterina Capperucci, Adriano Spreafico
Publikováno v:
Joint Bone Spine. 80:195-200
Objective Experimental and clinical data suggest that statins may protect bone by inhibiting bone resorption and/or stimulating bone formation. Interleukin-6 (IL-6) is produced by osteoblasts, and potently stimulates osteoclast activation playing a k
Autor:
Diletta Calamassi, C. Perra, S. Niccolini, Tiziana Nannelli, E. Rinaldini, C. Baldini, M. Poli
Publikováno v:
Prevenzione & Assistenza Dentale. 38:117-123
Riassunto Obiettivo Scopo dello studio e quello di stimare la prevalenza delle alterazioni della mucosa orale e le condizioni igieniche del cavo orale degli utenti in carico ai servizi di assistenza domiciliare di un’azienda sanitaria toscana. Mate
Autor:
Mauro Galeazzi, Laura Tinti, Claudio Catalani, Antonella Fioravanti, Claudio Valenti, C.A. Maggi, Stefania Meini, Paola Cucchi, Francesca Bellucci, S. Niccolini
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 385:777-786
This study investigates the effect of the selective and potent B2 receptor antagonist fasitibant (MEN16132) on the proinflammatory effect of bradykinin (BK) and its interaction with interleukin 1β (IL-1β) in human synoviocytes. PGE2 content was det
Publikováno v:
ICC
Alma Mater Studiorum Università di Bologna-IRIS
Alma Mater Studiorum Università di Bologna-IRIS
The market growth of VoIP infrastructures and services is pushing towards additional facilities to enrich service offer in an open way, thus representing also a differentiating aspect and a competitive advantage for service providers. We claim that t
Autor:
Andrea Cappelli, Mauro Galeazzi, S. Niccolini, Laura Tinti, Antonello Lamboglia, Mariangela Biava, Angela Di Capua, Maurizio Anzini, Antonio Giordani, Antonella Fioravanti, Nicola Antonio Pascarelli
Publikováno v:
Journal of Pharmacological Sciences, Vol 120, Iss 1, Pp 6-14 (2012)
The aim of this in vitro study was to examine the possible effect of [2-methyl-5-(4-methylsulphonyl)phenyl-1-phenyl-3-(2-n-propyloxyethyl)]-1H-pyrrole (VA441), a new selective cyclooxygenase (COX)-2 inhibitor, on human osteoarthritic (OA) chondrocyte
Autor:
S, Meini, P, Cucchi, L, Tinti, S, Niccolini, F, Bellucci, C, Catalani, C, Valenti, M, Galeazzi, A, Fioravanti, C A, Maggi
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 385(8)
This study investigates the effect of the selective and potent B(2) receptor antagonist fasitibant (MEN16132) on the proinflammatory effect of bradykinin (BK) and its interaction with interleukin 1β (IL-1β) in human synoviocytes. PGE(2) content was
Autor:
S. Niccolini, Nicola Antonio Pascarelli, Antonello Lamboglia, Laura Tinti, Roberto Cervone, Antonella Fioravanti
Publikováno v:
European journal of pharmacology. 670(1)
It is well known that estrogens are implicated in the pathogenesis of osteoarthritis. Raloxifene is a selective estrogen receptor modulator used in the treatment of osteoporosis, though little is known about the possible effects of raloxifene on cart